Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)
Vietnam · Delayed Price · Currency is VND 117,000
-1,500 (-1.27%)
At close: Oct 29, 2026
HNX:PMC Financials Overview
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 565,405 | 546,567 | 498,185 | 485,186 | 472,274 | 414,232 |
Revenue Growth | 8.42% | 9.71% | 2.68% | 2.73% | 14.01% | -10.10% |
Gross Profit Gross Profit Growth | 235,365 | 223,200 | 187,213 | 170,053 | 186,356 | 147,492 |
Operating Income Operating Income Growth | 97,808 | 97,900 | 90,484 | 84,408 | 90,768 | 72,580 |
Net Income Net Income Growth | 54,159 | 60,083 | 58,497 | 61,002 | 60,894 | 47,275 |
Earnings Per Share EPS Growth | 5803.23 | 6437.95 | 6268.00 | 6536.00 | 6524.89 | 5065.55 |
EPS Growth | 19.88% | 2.71% | -4.10% | 0.17% | 28.81% | -13.21% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Sales of Goods Sales of Goods Growth | 4,750 | 8,156 | 7,934 | 6,736 | 7,496 | 6,581 |
Finished Goods Finished Goods Growth | 541,564 | 538,410 | 490,251 | 478,451 | 464,777 | 407,651 |
Total Total Growth | 546,314 | 546,567 | 498,185 | 485,186 | 472,274 | 414,232 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 7,693 | 41,064 | 201,084 | 262,252 | 293,554 | 271,560 |
Total Debt Total Debt Growth | 59,362 | 181.01 | - | - | - | - |
Net Cash (Debt) Net Cash Growth | -51,670 | 40,883 | 201,084 | 262,252 | 293,554 | 271,560 |
Net Cash Growth | - | -79.67% | -23.32% | -10.66% | 8.10% | 19.88% |
Net Cash Per Share Net Cash Per Share Growth | -5536.47 | 4380.69 | 21546.50 | 28100.75 | 31454.72 | 29098.14 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 8,749 | 20,709 | 53,981 | 94,690 | 36,993 | 62,847 |
Capital Expenditures CapEx Growth | -50,233 | -79,641 | -14,754 | -8,012 | -5,318 | -3,962 |
Free Cash Flow Free Cash Flow Growth | -41,484 | -58,932 | 39,227 | 86,678 | 31,675 | 58,885 |
Free Cash Flow Growth | - | - | -54.74% | 173.65% | -46.21% | -17.07% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 41.63% | 40.84% | 37.58% | 35.05% | 39.46% | 35.61% |
Operating Margin | 17.30% | 17.91% | 18.16% | 17.40% | 19.22% | 17.52% |
Pretax Margin | 16.91% | 18.84% | 20.14% | 21.56% | 22.12% | 19.62% |
Profit Margin | 9.58% | 10.99% | 11.74% | 12.57% | 12.89% | 11.41% |
FCF Margin | -7.34% | -10.78% | 7.87% | 17.87% | 6.71% | 14.21% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2400.000 | - | 2400.000 | 19100.000 | 3000.000 | 2400.000 |
Dividend Per Share Growth | 1.53% | - | -87.44% | 536.67% | 25.00% | - |
Dividend Yield | 2.05% | - | 2.31% | 22.18% | 3.53% | 3.66% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.16 | 25.66 | 16.59 | 13.17 | 13.03 | 12.93 |
P/FCF Ratio | - | - | 24.74 | 9.27 | 25.04 | 10.38 |
PS Ratio | 1.93 | 2.82 | 1.95 | 1.66 | 1.68 | 1.48 |